Amgen announces it is investing $2.7 billion in BeiGene, taking a 20.5% stake in the Chinese biotech firm. Amgen will pay BeiGene shareholders $174.85 per share, a 25% premium to BeiGene’s closing …
More Amgen takes 20% stake in Chinese biotech BeiGene for $2.7 billion Videos